16
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

Dioctadecyldimethylammonium Chloride Bilayer Membrane Vesicle-Enhanced and Manganese (II)-Catalyzed Chemiluminescence for Determination of Adrenaline by a Flow-Injection Method

, , &
Pages 2445-2461 | Received 30 May 1989, Accepted 31 Jul 1989, Published online: 23 Oct 2006
 

Abstract

A new chemiluminescence system reinforced by use of a surfactant and a metal catalyst is demonstrated for selective determination of adrenaline by a flow-injection method. The weak light emission originating from an aerobic oxidation of adrenaline in an alkaline solution is dramatically enhanced by ordered surfactant molecular assemblies, dioctadecyldimethylammonium chloride bilayer membrane vesicles, with the largest enhancement factor of 1000 which has not ever been realized. The enhanced emission is further increased by a Mn(II) catalyst with an enhancement factor of ca. 40. The limit of determination(S/N=2) is 1×10−8M (0.2 ng in 100-μ1 injection), the linear range is four ordrers of magnitude, the sample throughput is 100 h−1. and the relative standard deviation(n=5) is 0.9 % for 5×10−7M adrenaline. Of other substances including dopamine, noradrenaline, and related compounds, p-hydroxymandelenic acid chemiluminesces most strongly after adrenaline, the 1×10−3M solution providing a signal 24% of that for 1×10−6M adrenaline.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.